Literature DB >> 21243532

Capecitabine-induced, nonneutropenic enterocolitis.

Vallerie L Gordon1, Gary A Harding, Piotr Czaykowski.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243532     DOI: 10.1007/s12029-010-9243-z

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  10 in total

1.  Lethal toxicity of uracil/tegafur in the treatment of sigmoid carcinoma.

Authors:  T M Bosch; I Meijerman; J H Beijnen; S W van Thiel; L T Vlasveld
Journal:  Ann Oncol       Date:  2006-12-14       Impact factor: 32.976

2.  Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Authors:  P M Hoff; R Ansari; G Batist; J Cox; W Kocha; M Kuperminc; J Maroun; D Walde; C Weaver; E Harrison; H U Burger; B Osterwalder; A O Wong; R Wong
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

3.  Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse event.

Authors:  Catharina Wenzel; Eleonora Urbauer; Christoph Schwarz; Georg Funk; Leopold Oehler; Gabriela V Kornek; Werner Scheithauer
Journal:  Anticancer Drugs       Date:  2006-08       Impact factor: 2.248

Review 4.  Neutropenic enterocolitis in adults: systematic analysis of evidence quality.

Authors:  Marcus Gorschlüter; Ulrich Mey; John Strehl; Carsten Ziske; Michael Schepke; Ingo G H Schmidt-Wolf; Tilman Sauerbruch; Axel Glasmacher
Journal:  Eur J Haematol       Date:  2005-07       Impact factor: 2.997

5.  Capecitabine as adjuvant treatment for stage III colon cancer.

Authors:  Chris Twelves; Alfred Wong; Marek P Nowacki; Markus Abt; Howard Burris; Alfredo Carrato; Jim Cassidy; Andrés Cervantes; Jan Fagerberg; Vassilis Georgoulias; Fares Husseini; Duncan Jodrell; Piotr Koralewski; Hendrik Kröning; Jean Maroun; Norbert Marschner; Joseph McKendrick; Marek Pawlicki; Riccardo Rosso; Johannes Schüller; Jean-François Seitz; Borut Stabuc; Jerzy Tujakowski; Guy Van Hazel; Jerzy Zaluski; Werner Scheithauer
Journal:  N Engl J Med       Date:  2005-06-30       Impact factor: 91.245

6.  Neutropenic enterocolitis in a patient with colorectal carcinoma: unusual course after treatment with 5-fluorouracil and leucovorin--a case report.

Authors:  U Kronawitter; N E Kemeny; L Blumgart
Journal:  Cancer       Date:  1997-08-15       Impact factor: 6.860

7.  Severe colitis after administration of UFT chemotherapy for temporal bone carcinoma.

Authors:  S Akay; O Ozütemiz; B Doganavsargil
Journal:  Expert Opin Drug Saf       Date:  2004-03       Impact factor: 4.250

Review 8.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.

Authors:  André B P van Kuilenburg
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

9.  Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.

Authors:  Ivo M Hennig; Jay D Naik; Sarah Brown; Alex Szubert; David A Anthoney; David P Jackson; Alan M Melcher; S Michael Crawford; Christopher Bradley; Julia M B Brown; Matthew T Seymour
Journal:  J Clin Oncol       Date:  2008-07-10       Impact factor: 44.544

10.  The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients.

Authors:  Aathavan Loganayagam; Monica Arenas-Hernandez; Lynette Fairbanks; Paul Ross; Jeremy D Sanderson; Anthony M Marinaki
Journal:  Cancer Chemother Pharmacol       Date:  2009-10-01       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.